SIGNAL TRANSDUCTION BY INSULIN-LIKE PEPTIDES IN NEURONS
Project Number5R01NS029809-02
Contact PI/Project LeaderSCHWARTZ, JAMES
Awardee OrganizationCOLUMBIA UNIV NEW YORK MORNINGSIDE
Description
Abstract Text
In invertebrates, insulin-like peptides have been convincingly localized to
neurons, and some have been shown to fulfill classical criteria expected of
neurotransmitters as well as their well-known activities as growth factors
and metabolic hormones. Examination of the electrophysiological effects of
the mammalian hormone on molluscan neurons reveals that insulin causes
hyperpolarization of certain identified neurons of the marine mollusc,
Aplysia. cDNA cloning, immunoblot analyses and immunocytochemistry provide
evidence for the presence of insulin-like tyrosine kinase receptor(s) in
bag cells, neuropil, and in as yet unidentified neurons in central Aplysia
ganglia. Immunocytochemistry with both vertebrate and invertebrate anti-
insulin antibodies shows staining of neurons, neuropil and gut, indicating
the existence of insulin-like Aplysia peptides. Three questions about the
presumptive actions of insulin and insulin-like peptides as
neurotransmitters that modulate synaptic action will be approached in the
nervous system of Aplysia: (1) What is the structure of the endogenous
molluscan neuropeptides whose action is mimicked by vertebrate insulin?
(2) Are tyrosine kinase signal transduction mechanisms used by these
insulin-like peptides to modulate synaptic transmission? and (3) What are
the neurophysiological and behavioral effects of insulin-like peptides?
The ability of invertebrate neurons to synthesize and release insulins
suggests that peptides of the insulin superfamily act not only as hormones
to control growth and metabolism, but also as modulatory neurotransmitters.
Neuropeptides that function as hormones or growth factors to initiate
longer-term metabolic, behavioral or developmental processes also can
produce short-term electrophysiological effects on neurons. Specifically,
our working hypothesis is that insulin-like peptides serve to integrate
behaviors, suppressing activities that are inappropriate when the animal
feeds: inking, a defensive behavior, through actions on cell L14, the
inking motor neuron, and egg-laying, a reproductive behavior, through
actions on the bag cells. The specific experimental advantages Aplysia
offer is the opportunity (1) to show that insulin-like peptide(s) act as
neuropeptides (as well as hormones); (2) to identify specific neural
circuits that mediate or integrate specific behaviors in addition (3) to
identify the particular biochemical second messenger pathway(s) and
neurophysiological mechanisms within those neurons that underlie the
behavior or behavioral changes. To our knowledge, this would be the first
opportunity to study a neuropeptide whose actions may be mediated through
a tyrosine kinase signal transduction pathway.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Aplysiaalternatives to animals in researchbiological signal transductioncalcium channelchloride channelsclone cellshigh performance liquid chromatographyimmunocytochemistryin situ hybridizationinositol phosphatesinsulininsulin receptorinsulinlike factorlaboratory rabbitmolecular cloningneuronsneuropeptide receptorneuropeptidesneurophysiologypeptide structurephosphorylationpotassium channelprotein purificationprotein sequenceprotein tyrosine kinasesecond messengerstransfectionvoltage /patch clamp
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
049179401
UEI
F4N1QNPB95M4
Project Start Date
01-April-1992
Project End Date
31-March-1996
Budget Start Date
01-April-1993
Budget End Date
31-March-1994
Project Funding Information for 1993
Total Funding
$164,393
Direct Costs
$124,561
Indirect Costs
$39,832
Year
Funding IC
FY Total Cost by IC
1993
National Institute of Neurological Disorders and Stroke
$164,393
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS029809-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS029809-02
Patents
No Patents information available for 5R01NS029809-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS029809-02
Clinical Studies
No Clinical Studies information available for 5R01NS029809-02
News and More
Related News Releases
No news release information available for 5R01NS029809-02
History
No Historical information available for 5R01NS029809-02
Similar Projects
No Similar Projects information available for 5R01NS029809-02